Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew J Flick

Showing results (51-60 of 117) with videos related to

Pageof 12
Sort By:
Frontiers in Cardiovascular Medicine|December 23, 2021
The Deleterious Effects of Impaired Fibrinolysis on Skeletal Development Are Dependent on Fibrin(ogen), but Independent of Interlukin-6Heather A Cole, Stephanie N Moore-Lotridge, Gregory D Hawley, et al.
Blood|May 19, 2019
Plasmin-mediated fibrinolysis enables macrophage migration in a murine model of inflammationLakmali Munasinghage Silva, Andrew Gary Lum, Collin Tran, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 10, 2017
Plasminogen Deficiency Delays the Onset and Protects from Demyelination and Paralysis in Autoimmune Neuroinflammatory DiseaseMaureen A Shaw, Zhen Gao, Kathryn E McElhinney, et al.
Biorxiv : the Preprint Server for Biology|September 4, 2023
4D intravital imaging studies identify platelets as the predominant cellular procoagulant surface in a mouse model of hemostasisAbigail Ballard-Kordeliski, Robert H Lee, Ellen C O'Shaughnessy, et al.
Science Advances|January 17, 2025
Targeting uPAR with an antibody-drug conjugate suppresses tumor growth and reshapes the immune landscape in pancreatic cancer modelsVirginia Metrangolo, Michaela Hansen Blomquist, Ananya Dutta, et al.
Blood|March 21, 2007
Tumor cell-associated tissue factor and circulating hemostatic factors cooperate to increase metastatic potential through natural killer cell-dependent and-independent mechanismsJoseph S Palumbo, Kathryn E Talmage, Jessica V Massari, et al.
Blood|March 30, 2026
Fibrin as a thrombin sink: a factor retaining a thrombus in the stillness phaseAlexandra A Yakusheva, Catherine Bourdon, Kim Ashley Jouffroy, et al.
Blood Advances|January 26, 2021
Plasminogen activator inhibitor 1 and venous thrombosis in pancreatic cancerYohei Hisada, Kenison B Garratt, Anaum Maqsood, et al.
Cancer Research|August 5, 2015
Colon Cancer Growth and Dissemination Relies upon Thrombin, Stromal PAR-1, and FibrinogenGregory N Adams, Leah Rosenfeldt, Malinda Frederick, et al.
The Journal of Clinical Investigation|July 2, 2014
Factor XIII activity mediates red blood cell retention in venous thrombiMaria M Aleman, James R Byrnes, Jian-Guo Wang, et al.
Pageof 12

Showing results (51-60 of 117) with videos related to

Sort By:
Pageof 12
Frontiers in Cardiovascular Medicine|December 23, 2021
The Deleterious Effects of Impaired Fibrinolysis on Skeletal Development Are Dependent on Fibrin(ogen), but Independent of Interlukin-6Heather A Cole, Stephanie N Moore-Lotridge, Gregory D Hawley, et al.
Blood|May 19, 2019
Plasmin-mediated fibrinolysis enables macrophage migration in a murine model of inflammationLakmali Munasinghage Silva, Andrew Gary Lum, Collin Tran, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 10, 2017
Plasminogen Deficiency Delays the Onset and Protects from Demyelination and Paralysis in Autoimmune Neuroinflammatory DiseaseMaureen A Shaw, Zhen Gao, Kathryn E McElhinney, et al.
Biorxiv : the Preprint Server for Biology|September 4, 2023
4D intravital imaging studies identify platelets as the predominant cellular procoagulant surface in a mouse model of hemostasisAbigail Ballard-Kordeliski, Robert H Lee, Ellen C O'Shaughnessy, et al.
Science Advances|January 17, 2025
Targeting uPAR with an antibody-drug conjugate suppresses tumor growth and reshapes the immune landscape in pancreatic cancer modelsVirginia Metrangolo, Michaela Hansen Blomquist, Ananya Dutta, et al.
Blood|March 21, 2007
Tumor cell-associated tissue factor and circulating hemostatic factors cooperate to increase metastatic potential through natural killer cell-dependent and-independent mechanismsJoseph S Palumbo, Kathryn E Talmage, Jessica V Massari, et al.
Blood|March 30, 2026
Fibrin as a thrombin sink: a factor retaining a thrombus in the stillness phaseAlexandra A Yakusheva, Catherine Bourdon, Kim Ashley Jouffroy, et al.
Blood Advances|January 26, 2021
Plasminogen activator inhibitor 1 and venous thrombosis in pancreatic cancerYohei Hisada, Kenison B Garratt, Anaum Maqsood, et al.
Cancer Research|August 5, 2015
Colon Cancer Growth and Dissemination Relies upon Thrombin, Stromal PAR-1, and FibrinogenGregory N Adams, Leah Rosenfeldt, Malinda Frederick, et al.
The Journal of Clinical Investigation|July 2, 2014
Factor XIII activity mediates red blood cell retention in venous thrombiMaria M Aleman, James R Byrnes, Jian-Guo Wang, et al.
Pageof 12